Good news everybody! The FDA has approved Nuvaxovid, the non-mRNA COVID vaccine from Novavax.

That doesn’t necessarily mean that everyone is going to be able to get this COVID vaccine though.
The Novavax COVID Vaccine Has Been Approved
Unlike other COVID vaccines, the FDA approval for Nuvaxovid is limited to:
- adults 65 years and older
- individuals 12 through 64 years who have at least one underlying condition that puts them at high risk for severe outcomes from COVID-19
While unusual for a COVID vaccine, these restrictions may not be as big a deal as some people might think though.
Why not?
There is a good chance that the folks at ACIP were going to switch to a non-universal recommendation for COVID vaccines soon.

A non-universal recommendation that would mean certain high-risk age groups and those with certain high-risk conditions should still get a vaccine.

And of course, the other big thing that makes the FDA limitations a bit of a non-factor is that the great majority of people have at least one condition that puts them at risk for severe COVID!
What kind of conditions?

In general, condition that put people at risk for severe COVID can include asthma, diabetes, and being immunosuppressed, etc.
“Diversity in vaccine production helps increase the number of patients vaccinated,” says Dr. Florescu. “Some might not accept mRNA vaccines, while others may be allergic to certain ingredients.”
Moths and tree bark: How the Novavax vaccine works
And that means that most people will be able to get the newly approved Nuvaxovid, the non-mRNA COVID vaccine from Novavax if they want it.
“The Novavax vaccine is the only non-mRNA updated COVID vaccine that has been available in the U.S. This vaccine is a protein adjuvant that had a 90% efficacy in its clinical trial, performing almost as well as the mRNA vaccines in their early trials. It is simpler to make than some of the other vaccines and can be stored in a refrigerator, making it easier to distribute.”
Comparing the COVID-19 Vaccines: How Are They Different?
A vaccine that had already been approved for emergency use and has been preferred by some who believe it causes fewer side effects than other COVID vaccines.
More on COVID Vaccines
- Do COVID Vaccines Cause Bell’s Palsy?
- Did the Head of Pfizer Research Say the COVID Vaccine is Female Sterilization?
- The New Normal – Blame Everything On COVID Vaccines
- Did Over 80 Percent of Pregnant Women in the Pfizer Vaccine Trial Have a Miscarriage?
- Is Canada Testing Aerosol COVID Vaccines That Can Be Delivered With Crop Dusters?
- How Many People Have Died After Listening to Bad Advice About COVID?
- FDA – NUVAXOVID
- Use of 2025–2026 COVID-19 Vaccines: Work Group Considerations
- Novavax has a good COVID-19 vaccine. How good is it? A very deep dive.
- Should you pick Novavax’s COVID-19 shot over mRNA options?
- Comparing the COVID-19 Vaccines: How Are They Different?
- Novavax says its COVID vaccine produces fewer, milder reactions than Pfizer version
- Is the Novavax COVID Vaccine Better Than mRNA Vaccines? What We Know So Far
- Moths and tree bark: How the Novavax vaccine works
Last Updated on May 19, 2025

You must be logged in to post a comment.